Crescita Therapeutics (TSE:CTX) Trading Up 1.1% – Time to Buy?

Crescita Therapeutics Inc. (TSE:CTX) traded up 1.1% on Tuesday . The company traded as high as C$0.45 and last traded at C$0.45. 21,000 shares changed hands during mid-day trading, a decline of 1% from the average session volume of 21,207 shares. The stock had previously closed at C$0.45.

Crescita Therapeutics Price Performance

The firm has a fifty day moving average of C$0.46 and a two-hundred day moving average of C$0.47. The company has a current ratio of 2.70, a quick ratio of 2.29 and a debt-to-equity ratio of 5.77. The company has a market capitalization of C$8.38 million, a PE ratio of 22.50 and a beta of -0.06.

Crescita Therapeutics (TSE:CTX) last announced its quarterly earnings results on Wednesday, November 5th. The company reported C$0.04 EPS for the quarter. Crescita Therapeutics had a negative return on equity of 15.60% and a negative net margin of 15.73%.The business had revenue of C$5.39 million for the quarter.

Crescita Therapeutics Company Profile

Crescita Therapeutics Inc is a Canadian commercial dermatology company with in-house research & development and manufacturing capabilities. The company offers a portfolio of non-prescription skincare products and early to commercial-stage prescription drug products and owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active ingredients into or through the skin.